Literature DB >> 18475902

Biologically-Active Gold(III) Complexes.

R V Parish1.   

Abstract

A review is given of the background to and results of the succesful pharmacological testing of [AuX(2)(damp)] (X = Cl, OAc; damp = 2-Me(2) NCH(2)C(6) H(4)) against a range of microbes, fungi and tumouts, culminating in in vivo xenografts of ZR-1-75. These are the first fully evaluated gold(III) complexes. The activity and reactions of the diacetato-complex bear a resemblance to cisplatin, and some of the relevant chemistry is discussed. Preliminary screening data for C,P-chelated tertiary phosphine derivatives of gold(III) are presented.

Entities:  

Year:  1999        PMID: 18475902      PMCID: PMC2365175          DOI: 10.1155/MBD.1999.271

Source DB:  PubMed          Journal:  Met Based Drugs        ISSN: 0793-0291


  6 in total

Review 1.  Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.

Authors:  Sunil Krishnan; Parmeswaran Diagaradjane; Sang Hyun Cho
Journal:  Int J Hyperthermia       Date:  2010-09-21       Impact factor: 3.914

2.  Stoichiometric to catalytic reactivity of the aryl cycloaurated species with arylboronic acids: insight into the mechanism of gold-catalyzed oxidative C(sp2)-H arylation.

Authors:  Qian Wu; Chenglong Du; Yumin Huang; Xingyan Liu; Zhen Long; Feijie Song; Jingsong You
Journal:  Chem Sci       Date:  2014-10-09       Impact factor: 9.825

3.  New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.

Authors:  Muhammad Altaf; Muhammad Monim-Ul-Mehboob; Abdel-Nasser Kawde; Giuseppe Corona; Roberto Larcher; Marcia Ogasawara; Naike Casagrande; Marta Celegato; Cinzia Borghese; Zahid H Siddik; Donatella Aldinucci; Anvarhusein A Isab
Journal:  Oncotarget       Date:  2017-01-03

Review 4.  Gold-Derived Molecules as New Antimicrobial Agents.

Authors:  Carlos Ratia; Raquel G Soengas; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 5.640

5.  A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria.

Authors:  Carlos Ratia; Virginio Cepas; Raquel Soengas; Yolanda Navarro; María Velasco-de Andrés; María José Iglesias; Francisco Lozano; Fernando López-Ortiz; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

6.  An Organogold Compound as Potential Antimicrobial Agent against Drug-Resistant Bacteria: Initial Mechanistic Insights.

Authors:  Parichita Chakraborty; Dorenda Oosterhuis; Riccardo Bonsignore; Angela Casini; Peter Olinga; Dirk-Jan Scheffers
Journal:  ChemMedChem       Date:  2021-07-23       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.